AppYea, Inc. (APYP) Stock
AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. The company developed the AppySleep app, an application with sensors that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns during sleep and identifies sleep apnea episodes without direct contact with the user; and AppySleep PRO, a wristband for the treatment of sleep apnea using biofeedback in combination with the AppySleep LAB app.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About AppYea, Inc.
AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. The company developed the AppySleep app, an application with sensors that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns during sleep and identifies sleep apnea episodes without direct contact with the user; and AppySleep PRO, a wristband for the treatment of sleep apnea using biofeedback in combination with the AppySleep LAB app. AppYea, Inc. was founded in 2012 and is headquartered in Gan Yavne, Israel.
AppYea, Inc. is headquartered in IL.
AppYea, Inc. (APYP) stock trades at $0.01 with a market capitalization of $6.50M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 0.81, price-to-sales of 1300.86. Over the past 52 weeks the stock has ranged between $0.01 and $0.03, and currently trades 66.7% below its 52-week high.
On profitability, AppYea, Inc. generates a return on equity (ROE) of -512.07%, return on capital employed of -142.76%.
Official website: www.appyea.com